Oncodesign is an innovative biotechnology company dedicated to the discovery of novel anticancer therapies. Using a pharmacological-based “Qualifying” approach aimed at the in vivo exploration and optimization of the therapeutic potential of individual molecules, they are able to offer the pharmaceutical industry a flexible, rapid, reliable and efficient means of identifying and selecting the most effective anticancer drugs possible for clinical use.